In NSCLC patients, the high expression of Ki67, VEGF-A, and VEGF-C is associated with an increased risk of lymph node metastasis, while VEGF-D was not correlated with lymph node metastasis. This evidence concerns the gene VEGFD and metastatic malignant neoplasm in the lymph nodes.